Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ENVB

Enveric Biosciences, Inc.

CIK 0000890821 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.35
↓ 0.08 (-5.59%)
as of Jul 10, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$5.27M
P/E Ratio
-0.64
EPS
-36.24
Dividend Yield
Not covered
52W Position
6%
Beta
1.38

Valuation multiples

Fwd P/E
23.09
PEG
Not covered
P/B
1.04
P/S
Not covered
EV/Revenue
Not covered
ROE
-162.4%
Valuation data covers 8,503/9,467 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.56$13.25

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$8.77M
Total Assets
$5.10M
Free Cash Flow
–

Recent news